{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:55Z","timestamp":1707524875965},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"DOI":"10.7759\/cureus.33340","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:51:14Z","timestamp":1672825874000},"source":"Crossref","is-referenced-by-count":0,"title":["Glycemic Control in Type 1 Diabetes Mellitus and COVID-19: What We Learned From the Lockdown Experience"],"prefix":"10.7759","author":[{"given":"Catarina","family":"Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Filipa","family":"Viegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edite","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) United States, February 12-March 16, 2020","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","unstructured":"CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020, 69:343-6.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-021-00705-9","article-title":"Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review","volume":"13","author":"Eberle C","year":"2021","unstructured":"Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021, 13:95. 10.1186\/s13098-021-00705-9","journal-title":"Diabetol Metab Syndr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2020.06.213","article-title":"Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature","volume":"49","author":"Bajgain KT","year":"2021","unstructured":"Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature. Am J Infect Control. 2021, 49:238-46. 10.1016\/j.ajic.2020.06.213","journal-title":"Am J Infect Control"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.endinu.2021.10.015","article-title":"Glycaemic control during the COVID-19 pandemic: a catastrophe or a sign of hope for the person with type 1 diabetes mellitus?","volume":"69","author":"Ramalho D","year":"2022","unstructured":"Ramalho D, Rouxinol-Dias A, Tavares P, et al.. Glycaemic control during the COVID-19 pandemic: a catastrophe or a sign of hope for the person with type 1 diabetes mellitus?. Endocrinol Diabetes Nutr. 2022, 69:476-82. 10.1016\/j.endinu.2021.10.015","journal-title":"Endocrinol Diabetes Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa149","article-title":"Impact of COVID-19 lockdown on glycemic control in adults with type 1 diabetes mellitus","volume":"4","author":"Pla B","year":"2020","unstructured":"Pla B, Arranz A, Knott C, Sampedro M, Jim\u00e9nez S, Hernando I, Marazuela M. Impact of COVID-19 lockdown on glycemic control in adults with type 1 diabetes mellitus. J Endocr Soc. 2020, 4:bvaa149. 10.1210\/jendso\/bvaa149","journal-title":"J Endocr Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-022-03038-2","article-title":"The impact of COVID-19 lockdown on glycaemic control in young adults with type 1 diabetes mellitus","author":"Lockhart M","year":"2022","unstructured":"Lockhart M, Green D, Smith D. The impact of COVID-19 lockdown on glycaemic control in young adults with type 1 diabetes mellitus. Ir J Med Sci. 2022, 1-3. 10.1007\/s11845-022-03038-2","journal-title":"Ir J Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2021.11.008","article-title":"Impact of COVID-19 lockdown on glycemic control in type 1 diabetes","volume":"29","author":"Duarte V","year":"2022","unstructured":"Duarte V, Mota B, Ferreira S, Costa C, Correia CC. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes. Arch Pediatr. 2022, 29:27-9. 10.1016\/j.arcped.2021.11.008","journal-title":"Arch Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108354","article-title":"The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 diabetes prone to hypoglycemia using standalone continuous glucose monitoring","volume":"167","author":"Mesa A","year":"2020","unstructured":"Mesa A, Vi\u00f1als C, Pueyo I 1st, Roca D, Vidal M, Gim\u00e9nez M, Conget I. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract. 2020, 167:108354. 10.1016\/j.diabres.2020.108354","journal-title":"Diabetes Res Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108379","article-title":"The challenge of diabetes home control in COVID-19 times: proof is in the pudding","volume":"168","author":"Cotovad-Bellas L","year":"2020","unstructured":"Cotovad-Bellas L, Tejera-P\u00e9rez C, Prieto-Tenreiro A, S\u00e1nchez-Bao A, Bellido-Guerrero D. The challenge of diabetes home control in COVID-19 times: proof is in the pudding. Diabetes Res Clin Pract. 2020, 168:108379. 10.1016\/j.diabres.2020.108379","journal-title":"Diabetes Res Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108348","article-title":"Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes","volume":"166","author":"Fern\u00e1ndez E","year":"2020","unstructured":"Fern\u00e1ndez E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020, 166:108348. 10.1016\/j.diabres.2020.108348","journal-title":"Diabetes Res Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.03.014","article-title":"Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: a simulation model using multivariate regression analysis","volume":"14","author":"Ghosal S","year":"2020","unstructured":"Ghosal S, Sinha B, Majumder M, Misra A. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: a simulation model using multivariate regression analysis. Diabetes Metab Syndr. 2020, 14:319-23. 10.1016\/j.dsx.2020.03.014","journal-title":"Diabetes Metab Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0125","article-title":"Impact of COVID-19 lockdown on the metabolic control parameters in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"46","author":"Wafa IA","year":"2022","unstructured":"Wafa IA, Pratama NR, Sofia NF, et al.. Impact of COVID-19 lockdown on the metabolic control parameters in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2022, 46:260-72. 10.4093\/dmj.2021.0125","journal-title":"Diabetes Metab J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14771","article-title":"The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: a systematic review and meta-analysis","volume":"24","author":"O'Mahoney LL","year":"2022","unstructured":"O'Mahoney LL, Highton PJ, Kudlek L, et al.. The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2022, 24:1850-60. 10.1111\/dom.14771","journal-title":"Diabetes Obes Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13110","article-title":"Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: what comes after a \"quarantine\"?","volume":"12","author":"Ceconi V","year":"2020","unstructured":"Ceconi V, Barbi E, Tornese G. Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: what comes after a \"quarantine\"?. J Diabetes. 2020, 12:946-8. 10.1111\/1753-0407.13110","journal-title":"J Diabetes"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2022.03.002","article-title":"Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes","volume":"69","author":"Rodriguez Escobedo R","year":"2022","unstructured":"Rodriguez Escobedo R, Alonso Felgueroso C, Martinez Tames G, Sanchez Ragnarsson C, Menendez Torre EL. Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes. Endocrinol Diabetes Nutr (Engl Ed). 2022, 69:305-7. 10.1016\/j.endien.2022.03.002","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i3.10366","article-title":"COVID-19 and type 1 diabetes: concerns and challenges","volume":"91","author":"Iughetti L","year":"2020","unstructured":"Iughetti L, Trevisani V, Cattini U, Bruzzi P, Lucaccioni L, Madeo S, Predieri B. COVID-19 and type 1 diabetes: concerns and challenges. Acta Biomed. 2020, 91:e2020033. 10.23750\/abm.v91i3.10366","journal-title":"Acta Biomed"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1016\/S1134-3230(10)62002-9","article-title":"Role of continuous glucose monitoring in diabetes management","volume":"26","author":"Moser EG","year":"2010","unstructured":"Moser EG, Crew LB, Garg SK. Role of continuous glucose monitoring in diabetes management. Av Diabetol. 2010, 26:73-8.","journal-title":"Av Diabetol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Laffel LM","year":"2020","unstructured":"Laffel LM, Kanapka LG, Beck RW, et al.. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. JAMA. 2020, 323:2388-96. 10.1001\/jama.2020.6940","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.26497\/na190022","article-title":"National consensus in the use of the flash glucose monitoring system in Portugal","volume":"14","author":"Cardoso H","year":"2019","unstructured":"Cardoso H, Carvalho D, Pape E, et al.. National consensus in the use of the flash glucose monitoring system in Portugal. Rev Port Endocrinol Diabetes Metab. 2019, 14:74-81. 10.26497\/na190022","journal-title":"Rev Port Endocrinol Diabetes Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/130714-glycemic-control-in-type-1-diabetes-mellitus-and-covid-19-what-we-learned-from-the-lockdown-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:37Z","timestamp":1707508057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/130714-glycemic-control-in-type-1-diabetes-mellitus-and-covid-19-what-we-learned-from-the-lockdown-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.33340","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}